198 related articles for article (PubMed ID: 21935871)
1. Morphological evaluation of parathyroid adenomas and immunohistochemical analysis of PCNA and Ki-67 proliferation markers.
Demıralay E; Altaca G; Demırhan B
Turk Patoloji Derg; 2011; 27(3):215-20. PubMed ID: 21935871
[TBL] [Abstract][Full Text] [Related]
2. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
3. Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases.
Erickson LA; Jin L; Papotti M; Lloyd RV
Am J Surg Pathol; 2002 Mar; 26(3):344-9. PubMed ID: 11859206
[TBL] [Abstract][Full Text] [Related]
4. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity.
Loda M; Lipman J; Cukor B; Bur M; Kwan P; DeLellis RA
Hum Pathol; 1994 Oct; 25(10):1050-6. PubMed ID: 7927309
[TBL] [Abstract][Full Text] [Related]
5. Nuclear DNA content, S-phase fraction analysis and expression of proliferating cell nuclear antigen (PCNA) of normal and hyperplastic/neoplastic parathyroid glands.
Suzuki S; Tsuchiya A; Hara K; Abe R
Fukushima J Med Sci; 1997 Jun; 43(1):41-50. PubMed ID: 9431783
[TBL] [Abstract][Full Text] [Related]
6. Functioning oxyphil adenoma of parathyroid gland. An ultrastructural and biochemical study.
McGregor DH; Lotuaco LG; Rao MS; Chu LL
Am J Pathol; 1978 Sep; 92(3):691-711. PubMed ID: 686153
[TBL] [Abstract][Full Text] [Related]
7. Increased protein kinase A type Iα regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism.
Hibi Y; Kambe F; Imai T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Ito A; Iwase K
Endocr J; 2013; 60(2):215-23. PubMed ID: 23197043
[TBL] [Abstract][Full Text] [Related]
8. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C
Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887
[TBL] [Abstract][Full Text] [Related]
9. EGFR and p53 expression and proliferative activity in parathyroid adenomas; an immunohistochemical study.
Gülkesen KH; Kiliçarslan B; Altunbaş HA; Karpuzoglu G
APMIS; 2001 Dec; 109(12):870-4. PubMed ID: 11846729
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
[TBL] [Abstract][Full Text] [Related]
11. Oxyphilic cell adenoma of parathyroid resulting in primary hyperparathyroidism and osteitis fibrosa cystica--a case report.
Prasad KK; Agarwal G; Mishra SK; Krishnani N
Indian J Pathol Microbiol; 2006 Jul; 49(3):448-50. PubMed ID: 17001919
[TBL] [Abstract][Full Text] [Related]
12. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.
Stojadinovic A; Hoos A; Nissan A; Dudas ME; Cordon-Cardo C; Shaha AR; Brennan MF; Singh B; Ghossein RA
Hum Pathol; 2003 Jan; 34(1):54-64. PubMed ID: 12605367
[TBL] [Abstract][Full Text] [Related]
14. Study of parathyroid transcription factor Gcm2 expression in parathyroid lesions.
Nonaka D
Am J Surg Pathol; 2011 Jan; 35(1):145-51. PubMed ID: 21164298
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity in colonic adenomas as a predictor of metachronous adenomas as assessed by proliferating cell nuclear antigen immunohistochemistry.
Paspatis GA; Karamanolis DG; Vasilakaki T; Zizi A; Xourgias V; Elemenoglou I; Hadziyannis SJ
Am J Gastroenterol; 1995 Apr; 90(4):597-602. PubMed ID: 7717318
[TBL] [Abstract][Full Text] [Related]
16. The expression of parathyroid hormone messenger RNA in normal and abnormal parathyroid tissue.
Kendall CH; Roberts PA; Pringle JH; Lauder I
J Pathol; 1991 Oct; 165(2):111-8. PubMed ID: 1744796
[TBL] [Abstract][Full Text] [Related]
17. Metachronous double parathyroid adenomas involving two different cell types: chief cell and oxyphil cell.
Zhou W; Katz MH; Deftos LJ; Snyder CS; Baird S; Bouvet M
Endocr Pract; 2003; 9(6):522-5. PubMed ID: 14715480
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic pitfalls in parathyroid gland cytology.
Knezević-Obad A; Tomić-Brzac H; Zarković K; Dodig D; Stromar IK
Coll Antropol; 2010 Mar; 34(1):25-9. PubMed ID: 20432729
[TBL] [Abstract][Full Text] [Related]
19. Expression of Ki-67, PCNA, and p27kip1 in canine pituitary corticotroph adenomas.
van Rijn SJ; Grinwis GC; Penning LC; Meij BP
Domest Anim Endocrinol; 2010 May; 38(4):244-52. PubMed ID: 20022446
[TBL] [Abstract][Full Text] [Related]
20. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen?
Holt PR; Moss SF; Kapetanakis AM; Petrotos A; Wang S
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):131-5. PubMed ID: 9037564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
